Miklos John R, Chinthakanan Orawee, Moore Robert D, Karp Deborah R, Nogueiras Gladys M, Davila G Willy
International Urogynecology Associates, Atlanta, Georgia and Beverly Hills, California.
International Urogynecology Associates, Atlanta, Georgia and Beverly Hills, California, Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Surg Technol Int. 2016 Oct 26;29:185-189.
Synthetic mesh utilized to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) can often result in postoperative complications. The objectives of this study were to determine: 1) the most common indications for mesh removal; 2) the incidences of the removal of specific mesh procedures (such as suburethral sling [SUS], transvaginal mesh [TVM], or sacrocolpopexy); and 3) the idences and types of surgical complications associated with mesh removal.
This was a retrospective study. Design Classification: Canadian Task Force II-3.
Three tertiary referral centers in the United States.
We examined data from all patients at the three centers who underwent surgical removal of synthetic materials from previous SUS, TVM, and sacrocolpopexy procedures for mesh-related complications from 2011 to 2013.
Patients underwent vaginal, intra-abdominal, and inguinal mesh revisions by cutting, partial removal, or total removal of the mesh for mesh-related complications.
Overall, 445 patients with complications underwent mesh removal laparoscopically, via groin dissection and/or transvaginally. There were a total of 506 mesh products removed. Of these, 56.5% were slings and 43.5% were for pelvic organ prolapse (POP). Synthetic mesh removed from patients included: transvaginal mesh (TVM) anterior for anterior vaginal prolapse, TVM posterior for posterior vaginal prolapse, sacrocolpopexy mesh, and suburethral slings (SUS) for stress urinary incontinence. Synthetic SUS removed included: retropubic (RPS), transobturator (TOT), and single-incision slings (SIS). TOT was the most common type of sling removed. Patients with a sling who only complained of vaginal pain with or without intercourse underwent a vaginal approach for surgical revision/removal of the sling (86.6%). Patients with an RPS with lower abdominal/suprapubic pain and vaginal pain underwent a vaginal and laparoscopic approach for sling removal (18.4%). Patients with a TOT sling who complained of vaginal and groin pain underwent a vaginal and inguinal approach for sling removal (4.3%). In patients who had POP mesh removal, 42.3% had an anterior TVM, 30.6% had a posterior TVM, 14% had both anterior and posterior TVMs, and 13.1% underwent sacrocolpopexy mesh removal. Complications encountered during mesh revision/removal surgery were: two blood transfusions from complete RPS removal (vaginal and laparoscopic approach), three urethral injuries during TOT sling removal (vaginal approach), two ureteral injuries during anterior vaginal wall mesh removal, and two rectal injuries during posterior vaginal wall mesh removal. All injuries were repaired at the time of mesh removal without recurrence.
In our study, the most common indication for mesh removal was pain with or without intercourse. The most common mesh procedure resulting in removal was the TOT sling. Use of a vaginal approach only for sling removal had the lowest incidence of intraoperative complications. Laparoscopic RPS removal had the highest incidence of required blood transfusions, anterior TVM had the highest incidence of ureteral injury, and posterior TVM had the highest incidence of rectal injury. Overall, sling, TVM, and sacrocolpopexy mesh removal are safe procedures when performed by experienced surgeons.
用于治疗压力性尿失禁(SUI)和盆腔器官脱垂(POP)的合成网片常常会导致术后并发症。本研究的目的是确定:1)网片移除的最常见指征;2)特定网片手术(如尿道下吊带术[SUS]、经阴道网片术[TVM]或骶骨阴道固定术)的移除发生率;3)与网片移除相关的手术并发症的发生率及类型。
这是一项回顾性研究。设计分类:加拿大工作组II-3。
美国的三个三级转诊中心。
我们检查了2011年至2013年期间三个中心所有因网片相关并发症而接受手术移除先前SUS、TVM和骶骨阴道固定术所用合成材料的患者的数据。
患者因网片相关并发症接受阴道、腹腔内和腹股沟网片修复手术,通过切割、部分移除或完全移除网片。
总体而言,445例有并发症的患者通过腹腔镜、腹股沟解剖和/或经阴道方式移除了网片。共移除了506个网片产品。其中,56.5%是吊带,43.5%用于盆腔器官脱垂(POP)。从患者身上移除的合成网片包括:用于阴道前壁脱垂的经阴道前网片(TVM)、用于阴道后壁脱垂的经阴道后网片、骶骨阴道固定术网片以及用于压力性尿失禁的尿道下吊带(SUS)。移除的合成SUS包括:耻骨后吊带(RPS)、经闭孔吊带(TOT)和单切口吊带(SIS)。TOT是最常被移除的吊带类型。仅抱怨伴有或不伴有性交的阴道疼痛的吊带患者接受了经阴道手术修复/移除吊带(86.6%)。伴有下腹部/耻骨上疼痛和阴道疼痛的RPS患者接受了经阴道和腹腔镜联合手术移除吊带(18.4%)。抱怨阴道和腹股沟疼痛的TOT吊带患者接受了经阴道和腹股沟联合手术移除吊带(4.3%)。在接受POP网片移除的患者中,42.3%移除了经阴道前网片,30.6%移除了经阴道后网片,14%同时移除了经阴道前网片和后网片,13.1%接受了骶骨阴道固定术网片移除。网片修复/移除手术期间遇到的并发症包括:完全移除RPS(经阴道和腹腔镜联合手术)导致2例输血,移除TOT吊带期间(经阴道手术)发生3例尿道损伤,移除阴道前壁网片期间发生2例输尿管损伤,移除阴道后壁网片期间发生2例直肠损伤。所有损伤均在网片移除时进行了修复,未复发。
在我们的研究中,网片移除的最常见指征是伴有或不伴有性交的疼痛。导致移除的最常见网片手术是TOT吊带术。仅采用经阴道方式移除吊带的术中并发症发生率最低。腹腔镜下移除RPS的输血需求发生率最高,经阴道前网片的输尿管损伤发生率最高,经阴道后网片的直肠损伤发生率最高。总体而言,由经验丰富的外科医生进行吊带、TVM和骶骨阴道固定术网片移除是安全的手术。